Stray magnetic field imaging of thin exfoliated iron halides flakes

Magnetic van der Waals materials are often proposed for use in future spintronic devices, aiming to leverage the combination of long-range magnetic order and near-atomic thinness to produce energy-efficient components. One class of material that has been discussed in this context are the iron halides FeCl$_2$ and FeBr$_2$, which are A-type antiferromagnets with strong uniaxial magnetocrystalline anisotropy. However, despite characterization of the bulk materials, the possibility for sustaining the magnetic behaviors that would underpin such applications in thin flakes has not been investigated. In this work, we use nitrogen-vacancy (NV) center microscopy to quantitatively image magnetism in individual exfoliated flakes of these iron halides, revealing the absence of magnetic remanence, a weak induced magnetization under bias field and variable behavior versus temperature. We show that our results are consistent with the antiferromagnetic behavior of the bulk material with a soft ferromagnetic uncompensated layer, indicating that extended ($>1~\mu$m) ferromagnetic domains are not sustained even at low temperatures (down to 4 K). Finally, we find that the magnetic order is strongly affected by the sample preparation, with a surprising diamagnetic order observed in a thin, hydrated sample.Comment: 15 pages, 13 figure

Stray magnetic field imaging of thin exfoliated iron halides flakes

Magnetic van der Waals materials are often proposed for use in future spintronic devices, aiming to leverage the combination of long-range magnetic order and near-atomic thinness to produce energy-efficient components. One class of material that has been discussed in this context are the iron halides FeCl2 and FeBr2, which are A-type antiferromagnets with strong uniaxial magnetocrystalline anisotropy. However, despite characterization of the bulk materials, the possibility for sustaining the magnetic behaviors that would underpin such applications in thin flakes has not been investigated. In this work, we use nitrogen-vacancy center microscopy to quantitatively image magnetism in individual exfoliated flakes of these iron halides, revealing the absence of magnetic remanence, a weak induced magnetization under bias field, and variable behavior versus temperature. We show that our results are consistent with the antiferromagnetic behavior of the bulk material with a soft ferromagnetic uncompensated layer, indicating that extended (&gt;1µm) ferromagnetic domains are not sustained even at low temperatures (down to 4 K). Finally, we find that the magnetic order is strongly affected by the sample preparation, with a surprising diamagnetic behavior observed in a thin, hydrated sample.<br/

Fabrication of angstrom-scale two-dimensional channels for mass transport

Fluidic channels at atomic scales regulate cellular trafficking and molecular filtration across membranes and thus play crucial roles in the functioning of living systems. However, constructing synthetic channels experimentally at these scales has been a significant challenge due to the limitations in nanofabrication techniques and the surface roughness of the commonly used materials. Angstrom-scale slit-like channels address this challenge, as these can be made with precise control over their dimensions and can be used to study the fluidic properties of gases, ions and water at unprecedented scales. Here, we provide a detailed fabrication method of the two-dimensional (2D) angstrom-scale channels, which can be assembled as a single channel or up to hundreds of channels made with atomic scale precision using layered crystals. The procedure includes the fabrication of the substrate, flake, spacer layer, flake transfers, van der Waals assembly, and post-processing. We further explain how to perform molecular transport measurements with the angstrom-scale channels, for the development of methods directed at unravelling interesting and anomalous phenomena that help shed light on the physics of nanofluidic transport systems. The procedure requires a total of 1 to 2 weeks for the fabrication of the 2D channel device and is suitable for users with prior experience in clean room working environments and nanofabrication

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. For example, a key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process versus those that measure fl ux through the autophagy pathway (i.e., the complete process including the amount and rate of cargo sequestered and degraded). In particular, a block in macroautophagy that results in autophagosome accumulation must be differentiated from stimuli that increase autophagic activity, defi ned as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (inmost higher eukaryotes and some protists such as Dictyostelium ) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the fi eld understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. It is worth emphasizing here that lysosomal digestion is a stage of autophagy and evaluating its competence is a crucial part of the evaluation of autophagic flux, or complete autophagy. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. Along these lines, because of the potential for pleiotropic effects due to blocking autophagy through genetic manipulation it is imperative to delete or knock down more than one autophagy-related gene. In addition, some individual Atg proteins, or groups of proteins, are involved in other cellular pathways so not all Atg proteins can be used as a specific marker for an autophagic process. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field

Planning walkable neighborhoods for “aging in place”: Lessons from five aging-friendly districts in Singapore

10.3390/su13041742Sustainability (Switzerland)1341-1

Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer

Early detection and discovery of new therapeutic targets are urgently needed to improve the breast cancer treatment outcome. Here we conducted an official clinical trial with cross-validation to corroborate human plasma Hsp90α as a novel breast cancer biomarker. Importantly, similar results were noticed in detecting early-stage breast cancer patients. Additionally, levels of plasma Hsp90α in breast cancer patients were gradually elevated as their clinical stages of regional lymph nodes advanced. In orthotopic breast cancer mouse models, administrating with recombinant Hsp90α protein increased both the primary tumor lymphatic vessel density and sentinel lymph node metastasis by 2 and 10 times, respectively. What is more, Hsp90α neutralizing antibody treatment approximately reduced 70% of lymphatic vessel density and 90% of sentinel lymph node metastasis. In the in vitro study, we demonstrated the role of extracellular Hsp90α (eHsp90α) as a pro-lymphangiogenic factor, which significantly enhanced migration and tube formation abilities of lymphatic endothelial cells (LECs). Mechanistically, eHsp90α signaled to the AKT pathway through low-density lipoprotein receptor-related protein 1 (LRP1) to upregulate the expression and secretion of CXCL8 in the lymphangiogenic process. Collectively, this study proves that plasma Hsp90α serves as an auxiliary diagnosis biomarker and eHsp90α as a molecular mediator promoting lymphangiogenesis in breast cancer